Household & Personal Products · Founded 1971 · www.sleepwellproducts.com / www.sheelafoam.com · BSE 540203 · NSE SFL · ISIN INE916U01025
No Notes Added Yet
Business
Sheela Foam Ltd. is India's largest manufacturer of foam and foam-based products. Its core business involves producing and selling mattresses, pillows, foam blocks, furniture cushions, and technical foams. The company operates through a mix of Business-to-Consumer (B2C) primarily under its flagship "Sleepwell" brand, and Business-to-Business (B2B) channels, catering to sectors like furniture, automotive, footwear, and general industrial applications. It makes money by selling these diversified foam products through its extensive distribution network and direct channels.
Revenue Mix
Sheela Foam's primary revenue drivers are mattresses, pillows, and comfort products sold under the "Sleepwell" brand in India, which is a significant contributor. Beyond branded consumer products, it also manufactures industrial foams and foam components. The company has an international presence through acquisitions, notably Joyce Foam in Australia (a major player in foam manufacturing) and Interplasp in Spain (producing flexible polyurethane foam). While precise segment-wise revenue splits can vary, the Indian Sleepwell brand and the international acquisitions collectively form its major revenue streams.
Industry
Sheela Foam operates in the Indian mattress and foam manufacturing industry, which is part of the broader Household & Personal Products sector. The Indian mattress market, in particular, has historically been fragmented, with a large unorganized sector. However, there's a significant ongoing shift towards the organized sector. Sheela Foam, with its "Sleepwell" brand, is the undisputed market leader in India's organized mattress industry, holding a dominant market share. In the industrial foam segment, it is also a leading player. Internationally, its acquisitions position it as a substantial foam manufacturer in Australia and Spain.
MOAT
Brand Equity: "Sleepwell" is a highly recognized, trusted, and premium brand in the Indian mattress market, built over decades. This strong brand recall enables premium pricing and customer loyalty.
Extensive Distribution Network: The company possesses a vast and deep distribution network across India, including exclusive outlets, multi-brand stores, and a growing online presence, making its products widely accessible.
Scale & Manufacturing Expertise: As the largest organized player, SFL benefits from economies of scale in raw material procurement and manufacturing, along with strong R&D capabilities for product innovation and quality.
Product Diversification: Its presence in both consumer (mattresses, pillows) and industrial foams provides revenue stability and diversified market access.
Growth Drivers
Shift to Organized Sector: The ongoing formalization of the Indian economy and increasing consumer preference for branded, quality products will continue to drive growth from the unorganized to the organized mattress market.
Rising Disposable Incomes & Urbanization: Increasing incomes, growing middle class, and rapid urbanization lead to higher discretionary spending on home comfort, housing, and lifestyle products.
Premiumization Trend: Consumers are increasingly willing to pay for technologically advanced, specialized, and comfortable sleep solutions, boosting demand for SFL's premium offerings.
E-commerce Expansion: Growth in online retail channels provides new avenues for sales and wider market reach, especially for direct-to-consumer models.
International Acquisitions: Successful integration and growth of its acquired international businesses (e.g., Joyce Foam, Interplasp) offer new geographies and additional revenue streams.
Risks
Raw Material Price Volatility: Key inputs like polyol and TDI (derivatives of crude oil) are susceptible to significant price fluctuations, which can directly impact profit margins.
Intense Competition: The market faces competition from other organized players, new-age online mattress brands, and a persistent unorganized sector, potentially leading to pricing pressures.
Economic Slowdown: As mattresses are largely discretionary purchases, an economic downturn could lead to reduced consumer spending and impact sales volumes.
Integration Risks: Challenges in successfully integrating acquired international businesses, including cultural differences, operational synergies, and financial performance.
Supply Chain Disruptions: Global events or logistical issues could disrupt the supply of raw materials or finished goods, affecting production and sales.
Management & Ownership
Sheela Foam Ltd. is promoted by the Gautam family, with Mr. Rahul Gautam serving as the Chairman and Managing Director. The promoter group maintains a significant ownership stake in the company, demonstrating long-term commitment. The management team is generally perceived as experienced and professional, having guided the company's growth and market leadership over several decades. The company is publicly listed, with a mix of institutional investors, non-promoter corporate bodies, and retail shareholders.
Outlook
Sheela Foam is well-positioned to capitalize on the secular growth trends in the Indian organized mattress and foam industry, driven by rising disposable incomes, urbanization, and a shift from unorganized to branded products. Its strong brand equity, extensive distribution, and manufacturing scale provide a robust foundation. The international acquisitions offer diversification and new growth avenues. However, the company remains susceptible to volatility in crude-oil-linked raw material prices, which can impact profitability. Intense competition, both from established players and emerging online brands, also necessitates continuous innovation and market vigilance. While its dominant market position and strong brand are significant advantages, effective management of commodity price fluctuations and successful integration of international operations will be crucial for sustained performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 879 | 845 | 810 | 813 | 967 | 850 | 821 | 875 | 1074 | 1050 |
| Other Income | 32 | 37 | 31 | 32 | 8 | 61 | 10 | 11 | 16 | 18 |
| Total Income | 911 | 882 | 840 | 845 | 975 | 910 | 831 | 885 | 1090 | 1068 |
| Total Expenditure | 803 | 765 | 750 | 742 | 879 | 823 | 746 | 788 | 960 | 933 |
| Operating Profit | 108 | 117 | 90 | 102 | 96 | 87 | 85 | 98 | 130 | 135 |
| Interest | 25 | 27 | 28 | 28 | 29 | 35 | 29 | 28 | 17 | 21 |
| Depreciation | 30 | 41 | 40 | 48 | 45 | 50 | 46 | 50 | 47 | 36 |
| Exceptional Income / Expenses | 0 | 34 | 31 | 0 | 0 | -0 | 0 | -8 | 0 | 16 |
| Profit Before Tax | 53 | 83 | 53 | 26 | 22 | 2 | 10 | 12 | 66 | 94 |
| Provision for Tax | 14 | 14 | 7 | 6 | 5 | -10 | 4 | 5 | 16 | 17 |
| Profit After Tax | 38 | 68 | 47 | 20 | 17 | 13 | 5 | 8 | 50 | 77 |
| Adjustments | -8 | -4 | -1 | -0 | 0 | 1 | 2 | 2 | 3 | 14 |
| Profit After Adjustments | 31 | 65 | 46 | 20 | 17 | 13 | 7 | 10 | 52 | 91 |
| Adjusted Earnings Per Share | 2.8 | 5.9 | 4.2 | 1.8 | 1.5 | 1.2 | 0.7 | 0.9 | 4.8 | 8.4 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1418 | 1550 | 1733 | 1965 | 2141 | 2174 | 2437 | 2866 | 2873 | 2982 | 3439 | 3820 |
| Other Income | 11 | 17 | 23 | 21 | 29 | 40 | 50 | 79 | 86 | 117 | 131 | 55 |
| Total Income | 1429 | 1567 | 1756 | 1986 | 2171 | 2214 | 2487 | 2945 | 2959 | 3099 | 3570 | 3874 |
| Total Expenditure | 1327 | 1374 | 1537 | 1749 | 1932 | 1873 | 2073 | 2551 | 2575 | 2682 | 3189 | 3427 |
| Operating Profit | 102 | 193 | 219 | 237 | 239 | 340 | 414 | 394 | 384 | 418 | 381 | 448 |
| Interest | 16 | 12 | 11 | 9 | 10 | 13 | 18 | 17 | 21 | 69 | 121 | 95 |
| Depreciation | 28 | 29 | 30 | 35 | 40 | 59 | 73 | 81 | 90 | 116 | 183 | 179 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -12 | 0 | 0 | 0 | 23 | 31 | 8 |
| Profit Before Tax | 58 | 152 | 178 | 193 | 189 | 256 | 324 | 296 | 273 | 256 | 108 | 182 |
| Provision for Tax | 15 | 47 | 52 | 60 | 56 | 62 | 84 | 78 | 72 | 61 | 13 | 42 |
| Profit After Tax | 43 | 105 | 126 | 134 | 134 | 194 | 240 | 219 | 201 | 195 | 96 | 140 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | -2 | -12 | 1 | 21 |
| Profit After Adjustments | 43 | 105 | 126 | 134 | 134 | 193 | 238 | 217 | 199 | 182 | 96 | 160 |
| Adjusted Earnings Per Share | 4.4 | 10.7 | 12.9 | 13.7 | 13.7 | 19.8 | 24.4 | 22.3 | 20.4 | 16.8 | 8.8 | 14.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 15% | 6% | 10% | 9% |
| Operating Profit CAGR | -9% | -1% | 2% | 14% |
| PAT CAGR | -51% | -24% | -13% | 8% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -3% | -14% | -10% | NA% |
| ROE Average | 3% | 8% | 13% | 20% |
| ROCE Average | 5% | 10% | 16% | 24% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 245 | 338 | 464 | 597 | 730 | 920 | 1184 | 1393 | 1598 | 2920 | 3035 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 8 | 8 | 61 | 60 |
| Borrowings | 73 | 35 | 22 | 8 | 6 | 157 | 133 | 228 | 284 | 945 | 530 |
| Other Non-Current Liabilities | 40 | 47 | 53 | 72 | 84 | 176 | 417 | 438 | 264 | 276 | 266 |
| Total Current Liabilities | 322 | 368 | 380 | 365 | 342 | 385 | 855 | 550 | 682 | 1129 | 1523 |
| Total Liabilities | 679 | 788 | 918 | 1043 | 1162 | 1644 | 2598 | 2616 | 2837 | 5331 | 5414 |
| Fixed Assets | 286 | 288 | 317 | 347 | 348 | 792 | 835 | 827 | 812 | 3078 | 3106 |
| Other Non-Current Assets | 21 | 36 | 55 | 103 | 128 | 95 | 646 | 1003 | 592 | 1378 | 845 |
| Total Current Assets | 373 | 465 | 546 | 592 | 686 | 757 | 1116 | 786 | 1433 | 875 | 1419 |
| Total Assets | 679 | 788 | 918 | 1043 | 1162 | 1644 | 2598 | 2616 | 2837 | 5331 | 5414 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 77 | 117 | 61 | 118 | 152 | 17 | 44 | 57 | 41 | 42 | 44 |
| Cash Flow from Operating Activities | 147 | 159 | 122 | 134 | 138 | 157 | 254 | 197 | 218 | 406 | 252 |
| Cash Flow from Investing Activities | -49 | -34 | 2 | -80 | -246 | -287 | -208 | -306 | -274 | -2258 | -29 |
| Cash Flow from Financing Activities | -59 | -25 | -67 | -20 | -27 | 157 | -32 | 93 | 56 | 1854 | -226 |
| Net Cash Inflow / Outflow | 40 | 100 | 57 | 34 | -135 | 27 | 13 | -17 | -0 | 2 | -3 |
| Closing Cash & Cash Equivalent | 117 | 217 | 118 | 152 | 17 | 44 | 57 | 41 | 42 | 44 | 41 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.37 | 10.73 | 12.87 | 13.7 | 13.71 | 19.83 | 24.37 | 22.28 | 20.39 | 16.78 | 8.84 |
| CEPS(Rs) | 7.24 | 13.73 | 15.98 | 17.32 | 17.76 | 25.97 | 32.08 | 30.7 | 29.77 | 28.55 | 25.59 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 25.12 | 34.69 | 47.52 | 61.22 | 74.83 | 94.27 | 121.38 | 142.73 | 163.82 | 268.42 | 278.41 |
| Core EBITDA Margin(%) | 5.81 | 10.37 | 10.35 | 10.79 | 9.78 | 13.82 | 14.56 | 10.38 | 9.68 | 9.13 | 6.58 |
| EBIT Margin(%) | 4.75 | 9.64 | 9.97 | 10.09 | 9.3 | 12.39 | 13.65 | 10.32 | 9.55 | 9.86 | 6.02 |
| Pre Tax Margin(%) | 3.7 | 8.96 | 9.39 | 9.65 | 8.85 | 11.79 | 12.95 | 9.76 | 8.86 | 7.78 | 2.85 |
| PAT Margin (%) | 2.75 | 6.17 | 6.63 | 6.67 | 6.25 | 8.94 | 9.6 | 7.21 | 6.52 | 5.91 | 2.52 |
| Cash Profit Margin (%) | 4.55 | 7.9 | 8.23 | 8.43 | 8.09 | 11.65 | 12.51 | 9.87 | 9.43 | 9.43 | 7.32 |
| ROA(%) | 6.54 | 14.27 | 14.71 | 13.64 | 12.13 | 13.85 | 11.32 | 8.39 | 7.37 | 4.76 | 1.78 |
| ROE(%) | 19.33 | 35.89 | 31.31 | 25.21 | 20.15 | 23.55 | 22.83 | 16.98 | 13.43 | 8.61 | 3.21 |
| ROCE(%) | 19.02 | 38.75 | 38.68 | 34.61 | 28.32 | 28.47 | 27.09 | 20.08 | 15.5 | 10.36 | 5.41 |
| Receivable days | 27.56 | 24.92 | 24.65 | 26.05 | 25.52 | 30.89 | 37.79 | 34.36 | 32.66 | 35.81 | 34.09 |
| Inventory Days | 28.47 | 23.97 | 24.19 | 29.05 | 30.66 | 34.76 | 39.56 | 37.86 | 38.25 | 37.19 | 33.12 |
| Payable days | 46.9 | 52.81 | 54.77 | 53.63 | 46.33 | 52.83 | 66.96 | 62.36 | 58.11 | 69.55 | 64.6 |
| PER(x) | 0 | 0 | 43.73 | 54.52 | 45.9 | 32.74 | 40.55 | 78.02 | 48.82 | 56.03 | 80.41 |
| Price/Book(x) | 0 | 0 | 11.84 | 12.21 | 8.41 | 6.89 | 8.14 | 12.18 | 6.08 | 3.5 | 2.55 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.03 | -0.06 | 3.08 | 3.65 | 2.87 | 2.99 | 4.02 | 6.02 | 3.53 | 3.84 | 2.59 |
| EV/Core EBITDA(x) | 0.44 | -0.44 | 24.36 | 30.24 | 25.77 | 19.1 | 23.62 | 43.78 | 26.42 | 27.43 | 23.36 |
| Net Sales Growth(%) | 11.53 | 9.33 | 11.8 | 13.42 | 8.96 | 1.5 | 12.13 | 17.58 | 0.27 | 3.79 | 15.32 |
| EBIT Growth(%) | 33.29 | 121.94 | 15.45 | 7.04 | -1.54 | 35.32 | 26.79 | -8.26 | -6.12 | 10.33 | -29.5 |
| PAT Growth(%) | 53.28 | 145.38 | 19.9 | 6.49 | 0.02 | 45.27 | 23.61 | -8.92 | -8.18 | -3.15 | -50.89 |
| EPS Growth(%) | 53.28 | 145.39 | 19.9 | 6.49 | 0.03 | 44.63 | 22.9 | -8.58 | -8.46 | -17.69 | -47.33 |
| Debt/Equity(x) | 0.59 | 0.34 | 0.13 | 0.08 | 0.04 | 0.23 | 0.17 | 0.24 | 0.29 | 0.44 | 0.4 |
| Current Ratio(x) | 1.16 | 1.26 | 1.44 | 1.62 | 2 | 1.97 | 1.31 | 1.43 | 2.1 | 0.78 | 0.93 |
| Quick Ratio(x) | 0.79 | 0.98 | 1.05 | 1.15 | 1.46 | 1.38 | 0.94 | 0.86 | 1.62 | 0.47 | 0.7 |
| Interest Cover(x) | 4.55 | 14.02 | 17.22 | 23.32 | 20.68 | 20.73 | 19.31 | 18.46 | 13.96 | 4.73 | 1.9 |
| Total Debt/Mcap(x) | 0 | 0 | 0.01 | 0.01 | 0 | 0.03 | 0.02 | 0.02 | 0.05 | 0.13 | 0.16 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.48 | 65.48 | 65.48 | 65.48 | 65.7 | 65.69 | 65.69 | 65.69 | 65.69 | 65.69 |
| FII | 6.12 | 6.32 | 6.4 | 6.59 | 6.55 | 6.23 | 4.63 | 4.07 | 4.18 | 4.15 |
| DII | 24.99 | 24.53 | 23.4 | 22.3 | 21.04 | 21.17 | 21.13 | 21.11 | 20.39 | 20.56 |
| Public | 3.4 | 3.67 | 4.72 | 5.63 | 6.71 | 6.91 | 8.56 | 9.14 | 9.75 | 9.6 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.12 | 7.12 | 7.12 | 7.12 | 7.14 | 7.14 | 7.14 | 7.14 | 7.14 | 7.14 |
| FII | 0.67 | 0.69 | 0.7 | 0.72 | 0.71 | 0.68 | 0.5 | 0.44 | 0.45 | 0.45 |
| DII | 2.72 | 2.67 | 2.54 | 2.42 | 2.29 | 2.3 | 2.3 | 2.29 | 2.22 | 2.23 |
| Public | 0.37 | 0.4 | 0.51 | 0.61 | 0.73 | 0.75 | 0.93 | 0.99 | 1.06 | 1.04 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +15% | +6% | +10% | +9% |
| Operating Profit CAGR | -9% | -1% | +2% | +14% |
| PAT CAGR | -51% | -24% | -13% | +8% |
| Share Price CAGR | -3% | -14% | -10% | — |
| ROE Average | +3% | +8% | +13% | +20% |
| ROCE Average | +5% | +10% | +16% | +24% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.48 | 65.48 | 65.48 | 65.48 | 65.7 | 65.69 | 65.69 | 65.69 | 65.69 | 65.69 |
| FII | 6.12 | 6.32 | 6.4 | 6.59 | 6.55 | 6.23 | 4.63 | 4.07 | 4.18 | 4.15 |
| DII | 24.99 | 24.53 | 23.4 | 22.3 | 21.04 | 21.17 | 21.13 | 21.11 | 20.39 | 20.56 |
| Public | 34.52 | 34.52 | 34.52 | 34.52 | 34.3 | 34.31 | 34.31 | 34.31 | 34.31 | 34.31 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.12 | 7.12 | 7.12 | 7.12 | 7.14 | 7.14 | 7.14 | 7.14 | 7.14 | 7.14 |
| FII | 0.67 | 0.69 | 0.7 | 0.72 | 0.71 | 0.68 | 0.5 | 0.44 | 0.45 | 0.45 |
| DII | 2.72 | 2.67 | 2.54 | 2.42 | 2.29 | 2.3 | 2.3 | 2.29 | 2.22 | 2.23 |
| Public | 3.75 | 3.75 | 3.75 | 3.75 | 3.73 | 3.73 | 3.73 | 3.73 | 3.73 | 3.73 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 | 10.87 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.